Mycobacterium tuberculosis 10-kDa co-chaperonin regulates the expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in human osteoblasts

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 919-924

Spandidos Publications

Access to resources Recommend Favorite

Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)

By    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3212-3218

Spandidos Publications

Access to resources Recommend Favorite

Receptor Activator of Nuclear Factor-B Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis

By Sasaki Atsushi   Ishikawa Kenji   Haraguchi Naotsugu   Inoue Hiroshi   Ishio Tetsuya   Shibata Kohei   Ohta Masayuki   Kitano Seigo   Mori Masaki  

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1191-1199

Springer Publishing Company

Access to resources Recommend Favorite

Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton

By Mountzios Giannis   Dimopoulos Meletios-Athanassios   Bamias Aristotelis   Papadopoulos George   Kastritis Efstathios   Syrigos Konstantinos   Pavlakis George   Terpos Evangelos  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 221-229

Informa Healthcare

Access to resources Recommend Favorite

Recombinant receptor activator of nuclear factor κB exhibits more marked inhibitory effects on osteoclasts compared with recombinant osteoprotegerin in vitro and in vivo

By          

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 631-638

Spandidos Publications

Access to resources Recommend Favorite